syndrome diseases including Heart, Cardiovascular, Diabetes, and Rheumatoid Arthritis – by reducing inflammation.

The government of the United States has a patent on the pharmacological use of cannabinoids. The patent itself reads:

“Cannabinoids have been found to have antioxidant properties unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory, and autoimmune diseases.”

Cannabinoids have enormous potential as the basis for new antioxidant and neuroprotectant drugs for the treatment of diseases and conditions including:

• Neurological diseases and conditions including Stroke, Chronic pain, Parkinson’s Disease, Alzheimer’s, Autism, Multiple Sclerosis, ADD, ADHD, PTSD, Neuropathy, and HIV-induced Dementia
• Osteoporosis
• Inflammatory Bowel Diseases
• Depression and other psychiatric disorders
• Addiction
• Traumatic Brain Injury
• Epilepsy
• Cancer

Cannabinoids that do not contain THC are better-tolerated treatments for diseases because they are neither toxic nor psychoactive cannabinoids. But THC has certain properties that other cannabinoids don’t have and is appropriate for many diseases because the health benefits of using THC are greater than the adverse effects.

One of the most important non-THC cannabinoids is cannabidiol (CBD), the molecule on which our research is focussed.